Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Truntzer

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Oncotarget|December 20, 2018
Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancerFrancois Ghiringhelli, Caroline Truntzer
BMC Bioinformatics|October 16, 2008
Comparative optimism in models involving both classical clinical and gene expression informationCaroline Truntzer, Delphine Maucort-Boulch, Pascal Roy
British Journal of Cancer|March 23, 2019
Cell lines and immune classification of glioblastoma define patient's prognosisQuentin Klopfenstein, Caroline Truntzer, Julie Vincent, et al.
Proteomics|May 1, 2010
Multivariate denoising methods combining wavelets and principal component analysis for mass spectrometry dataElise Mostacci, Caroline Truntzer, Hervé Cardot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2020
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging conceptsJean-David Fumet, Caroline Truntzer, Mark Yarchoan, et al.
Journal for Immunotherapy of Cancer|October 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short reportNicolas Roussot, Julie Lecuelle, Lorraine Dalens, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapyIsabelle Desmoulins, Hélène Bellio, Nathalie Méjean, et al.
Cancers|April 30, 2021
Using Exome Sequencing to Improve Prediction of FOLFIRINOX First Efficacy for Pancreatic AdenocarcinomaJulie Lecuelle, Anne Aarnink, Zoé Tharin, et al.
Cancers|August 30, 2020
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 EfficacyElise Ballot, Sylvain Ladoire, Bertrand Routy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Oncotarget|December 20, 2018
Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancerFrancois Ghiringhelli, Caroline Truntzer
BMC Bioinformatics|October 16, 2008
Comparative optimism in models involving both classical clinical and gene expression informationCaroline Truntzer, Delphine Maucort-Boulch, Pascal Roy
British Journal of Cancer|March 23, 2019
Cell lines and immune classification of glioblastoma define patient's prognosisQuentin Klopfenstein, Caroline Truntzer, Julie Vincent, et al.
Proteomics|May 1, 2010
Multivariate denoising methods combining wavelets and principal component analysis for mass spectrometry dataElise Mostacci, Caroline Truntzer, Hervé Cardot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2020
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging conceptsJean-David Fumet, Caroline Truntzer, Mark Yarchoan, et al.
Journal for Immunotherapy of Cancer|October 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short reportNicolas Roussot, Julie Lecuelle, Lorraine Dalens, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapyIsabelle Desmoulins, Hélène Bellio, Nathalie Méjean, et al.
Cancers|April 30, 2021
Using Exome Sequencing to Improve Prediction of FOLFIRINOX First Efficacy for Pancreatic AdenocarcinomaJulie Lecuelle, Anne Aarnink, Zoé Tharin, et al.
Cancers|August 30, 2020
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 EfficacyElise Ballot, Sylvain Ladoire, Bertrand Routy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
Pageof 11